S&P 500 7,500.58 ▲ 80.48 (+1.08%) DOW 51,564.70 ▲ 72.15 (+0.14%) NASDAQ 26,517.93 ▲ 496.28 (+1.91%) US Markets Open â€ĸ 12:04 PM ET

CCM

Concord Medical Services Holdings Limited

Price Chart
Latest Quote

$5.32

-0.15 (-2.74%)
Current Price
Previous Close $5.47
Open $5.64
Day High $5.96
Day Low $5.21
Volume 23,856
Fetched: 2026-06-19T16:04:52
Stock Information
Note: Financial values converted from CNY to USD
Shares Outstanding 2.82M
Total Debt $537.08M
Cash Equivalents $44.00M
Revenue $68.04M
Net Income $-13.71M
Sector Healthcare
Industry Medical Care Facilities
Market Cap $23.10M
EPS (TTM) $-3.14
Exchange NYQ
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$7.31B
Sales$68.04M
Income$-13.71M
Book/sh$-71.61
Cash/sh$105.77
Employees610
Financial Ratios
Quick Ratio0.17
Current Ratio0.48
Debt/Eq196.47
Returns & Margins
ROA-2.25%
ROE-21.88%
Gross Margin5.61%
Operating Margin-36.43%
Profit Margin-20.15%
Ownership
Insider Ownership18.00%
Institutional Ownership0.44%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E-35.47
PEG0.56
P/S0.05
P/B-0.07
Analyst Data
Recommendationnone
Technical Indicators
SMA20$4.82
SMA50$4.59
SMA200$4.57
RSI56.39
ATR0.4514
Shares Float1.40M
Short Float0.58%
Short Ratio0.14
Volatility-0.98
Rel Volume0.52
Performance History
Week+17.18%
Month+7.69%
Quarter+45.75%
6 Months+22.86%
YTD+24.59%
Year-5.00%
3 Years-59.39%
5 Years-82.27%
10 Years-86.15%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-18 $5.32 24,600
2026-06-17 $5.47 130,600
2026-06-16 $4.70 43,800
2026-06-15 $4.37 24,500
2026-06-12 $4.41 5,600
2026-06-11 $4.54 14,300
2026-06-10 $4.63 2,200
2026-06-09 $4.71 7,100
2026-06-08 $4.78 5,600
2026-06-05 $4.78 65,400
2026-06-04 $5.06 91,300
2026-06-03 $4.51 31,100
2026-06-02 $4.83 124,700
2026-06-01 $5.00 76,700
2026-05-29 $4.93 7,800
2026-05-28 $4.90 13,000
2026-05-27 $4.87 62,900
2026-05-26 $4.89 95,500
2026-05-22 $4.91 65,300
2026-05-21 $4.75 51,200
2026-05-20 $4.75 12,600
2026-05-19 $4.94 1,000
About Concord Medical Services Holdings Limited

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, and helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.

Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $64,283,870 $68,487,298 $90,801,665 $92,352,071
Cost Of Revenue $64,283,870 $68,487,298 $90,801,665 $92,352,071
Total Revenue $68,102,062 $56,780,581 $79,472,641 $69,813,365
Operating Revenue $68,102,062 $56,780,581 $79,472,641 $69,813,365
Expenses
Interest Expense $22,526,432 $28,570,855 $24,499,635 $17,798,759
Total Expenses $103,495,206 $135,478,019 $147,940,271 $147,459,059
Other Income Expense $1,274,456 $6,181,067 $9,202,466 $-30,243,856
Other Non Operating Income Expenses $-1,138,847 $-1,369,988 $-1,593,736 $-32,032,945
Net Non Operating Interest Income Expense $-21,094,333 $-26,503,155 $-22,897,766 $-16,316,823
Interest Expense Non Operating $22,526,432 $28,570,855 $24,499,635 $17,798,759
Operating Expense $39,211,336 $66,990,721 $57,138,605 $55,106,988
Selling And Marketing Expense $7,717,129 $7,190,961 $8,325,667 $9,091,701
General And Administrative Expense $31,494,207 $59,799,761 $48,812,938 $46,015,287
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-13,725,173 $-45,583,912 $-44,018,570 $-72,412,557
Net Interest Income $-21,094,333 $-26,503,155 $-22,897,766 $-16,316,823
Interest Income $1,432,099 $2,067,701 $1,601,869 $1,481,936
Normalized Income $-14,088,078 $-51,109,120 $-51,398,906 $-71,661,231
Net Income From Continuing And Discontinued Operation $-13,725,173 $-45,583,912 $-44,018,570 $-72,412,557
Total Operating Income As Reported $-38,670,232 $-78,697,439 $-68,467,629 $-77,645,694
Net Income Common Stockholders $-13,725,173 $-45,583,912 $-44,018,570 $-72,412,557
Net Income $-13,725,173 $-45,583,912 $-44,018,570 $-72,412,557
Net Income Including Noncontrolling Interests $-56,109,783 $-96,430,833 $-78,529,000 $-113,720,579
Net Income Continuous Operations $-56,109,783 $-96,430,833 $-78,529,000 $-113,720,579
Pretax Income $-55,213,020 $-99,019,526 $-82,162,930 $-124,206,374
Special Income Charges $2,264,237 $7,154,138 $5,450,969 $-9,101,610
Earnings From Equity Interest $1,929,430 $1,877,523 $3,074,341 $2,609,692
Interest Income Non Operating $1,432,099 $2,067,701 $1,601,869 $1,481,936
Operating Income $-35,393,144 $-78,697,439 $-68,467,629 $-77,645,694
Gross Profit $3,818,192 $-11,706,717 $-11,329,024 $-22,538,706
Per Share
Diluted EPS - $-10.43 $-10.07 $-16.59
Basic EPS - $-10.43 $-10.07 $-16.59
Other
Tax Effect Of Unusual Items $120,968 $148,325 $341,525 $-69,277
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-11,098,031 $-56,785,461 $-46,388,987 $-85,946,074
Total Unusual Items $483,873 $5,673,533 $7,721,861 $-820,603
Total Unusual Items Excluding Goodwill $483,873 $5,673,533 $7,721,861 $-820,603
Reconciled Depreciation $22,072,431 $19,336,743 $18,996,168 $19,640,938
EBITDA (Bullshit earnings) $-10,614,157 $-51,111,928 $-38,667,126 $-86,766,677
EBIT $-32,686,588 $-70,448,670 $-57,663,294 $-106,407,615
Diluted NI Availto Com Stockholders $-13,725,173 $-45,583,912 $-44,018,570 $-72,412,557
Otherunder Preferred Stock Dividend $0 $0 $0 $0
Minority Interests $42,384,610 $50,846,921 $34,510,430 $41,308,022
Tax Provision $896,763 $-2,588,693 $-3,633,930 $-10,485,795
Gain On Sale Of Business $5,541,325 $7,154,138 $5,450,969 $-9,101,610
Impairment Of Capital Assets $3,277,088 $0 $0 $0
Gain On Sale Of Security $-1,780,364 $-1,480,605 $2,270,892 $8,281,007
Selling General And Administration $39,211,336 $66,990,721 $57,138,605 $55,106,988
Other Gand A $31,494,207 $59,799,761 $48,812,938 $46,015,287
Diluted Average Shares - $646,021 $646,021 $646,021
Basic Average Shares - $646,021 $646,021 $646,021
Gain On Sale Of Ppe - - $9,169 $-444
Fetched: 2026-06-14
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $-489,469,349 $-522,467,823 $-505,540,834 $-473,321,113
Total Assets $968,243,797 $994,718,706 $895,275,495 $888,027,895
Total Non Current Assets $828,950,839 $849,205,935 $804,000,899 $775,666,361
Other Non Current Assets $488,162 $471,007 $937,726 $1,159,699
Non Current Prepaid Assets $203,931 $396,622 $751,985 $1,072,300
Goodwill And Other Intangible Assets $178,455,049 $185,236,817 $191,741,157 $197,672,154
Other Intangible Assets $93,834,007 $100,615,775 $106,645,263 $112,576,260
Current Assets $139,292,958 $145,512,771 $91,274,595 $112,361,534
Other Current Assets $81,807,419 $78,046,753 $61,067,710 $56,986,877
Restricted Cash $136,200 $3,069,756 $4,773,665 $156,756
Inventory $6,797,444 $4,945,357 $5,966,637 $12,545,658
Receivables $6,514,100 $7,566,879 $10,868,812 $19,264,872
Accounts Receivable $6,514,100 $7,566,879 $10,868,812 $19,264,872
Allowance For Doubtful Accounts Receivable $-6,825,690 $-6,341,816 $-4,508,362 $-1,148,164
Gross Accounts Receivable $13,339,790 $13,908,696 $15,377,174 $20,413,035
Cash Cash Equivalents And Short Term Investments $44,037,795 $51,884,025 $8,597,772 $23,407,371
Cash And Cash Equivalents $44,037,647 $31,975,862 $8,597,772 $23,407,371
Investmentin Financial Assets - - $2,798,539 $7,408,349
Current Deferred Assets - - - $29,577
Prepaid Assets - - - $384,644
Receivables Adjustments Allowances - - - $-2,556,898
Other Receivables - - - $9,051,625
Taxes Receivable - - - $6,581,091
Loans Receivable - - - $43,496,839
Non Current Accounts Receivable - - - -
Accrued Interest Receivable - - - -
Debt
Net Debt $468,609,115 $522,051,532 $443,362,671 $420,834,760
Total Debt $537,553,815 $581,288,450 $487,378,283 $479,123,156
Long Term Debt And Capital Lease Obligation $386,271,092 $421,849,237 $326,380,975 $398,009,456
Long Term Debt $367,564,035 $401,309,170 $297,838,513 $368,439,799
Current Debt And Capital Lease Obligation $151,282,723 $159,439,212 $160,997,308 $81,113,700
Current Debt $145,082,727 $152,718,224 $154,121,930 $75,802,332
Other Current Borrowings $99,243,717 $73,750,603 $108,009,780 $52,807,111
Liabilities
Total Liabilities Net Minority Interest $694,643,018 $755,481,066 $636,925,746 $589,946,410
Total Non Current Liabilities Net Minority Interest $405,618,926 $441,177,107 $348,347,669 $424,134,622
Other Non Current Liabilities $611,348 $491,415 $670,354 $559,737
Non Current Deferred Liabilities $11,091,524 $12,255,068 $14,719,982 $16,648,229
Non Current Deferred Taxes Liabilities $11,091,524 $12,255,068 $14,719,982 $16,648,229
Current Liabilities $289,024,092 $314,303,958 $288,578,077 $165,811,788
Current Deferred Liabilities $14,152,111 $6,824,950 $8,785,436 $14,906,906
Payables And Accrued Expenses $123,589,258 $148,039,796 $118,771,228 $69,008,881
Payables $55,383,825 $67,055,198 $61,534,577 $57,916,174
Other Payable $32,146,372 $32,491,235 $39,887,901 $31,958,708
Total Tax Payable $5,596,782 $5,076,973 $2,534,863 $4,255,926
Income Tax Payable $1,119,327 $240,014 $225,078 $120,968
Accounts Payable $17,640,672 $29,486,991 $19,111,813 $21,701,540
Other Current Liabilities - - $24,105 $782,301
Derivative Product Liabilities - - - $0
Equity
Common Stock Equity $-311,014,300 $-337,231,006 $-313,799,677 $-275,648,959
Total Equity Gross Minority Interest $273,600,778 $239,237,640 $258,349,748 $298,081,485
Stockholders Equity $-311,014,300 $-337,231,006 $-313,799,677 $-275,648,959
Gains Losses Not Affecting Retained Earnings $-11,174,782 $-11,438,605 $-9,674,361 $-4,106,120
Other Equity Adjustments $-11,174,782 $-11,438,605 $-9,674,361 $-4,106,120
Retained Earnings $-660,392,862 $-646,667,690 $-601,083,778 $-557,065,208
Long Term Equity Investment $62,406,939 $69,825,343 $58,371,063 $57,345,789
Preferred Securities Outside Stock Equity - - - -
Other
Treasury Shares Number $1,789,658 $1,789,658 $1,789,658 $1,789,658
Ordinary Shares Number $19,262,015 $19,262,015 $19,262,015 $19,262,015
Share Issued $21,051,673 $21,051,673 $21,051,673 $21,051,673
Tangible Book Value $-489,469,349 $-522,467,823 $-505,540,834 $-473,321,113
Invested Capital $201,632,462 $216,796,389 $138,160,765 $168,593,172
Working Capital $-149,731,134 $-168,791,188 $-197,303,482 $-53,450,254
Capital Lease Obligations $24,907,053 $27,261,055 $35,417,840 $34,881,025
Total Capitalization $56,549,735 $64,078,165 $-15,961,164 $92,790,840
Minority Interest $584,615,079 $576,468,646 $572,149,426 $573,730,443
Treasury Stock $1,035 $1,035 $1,035 $1,035
Additional Paid In Capital $360,538,852 $320,860,797 $296,943,968 $285,507,877
Capital Stock $15,528 $15,528 $15,528 $15,528
Common Stock $15,528 $15,528 $15,528 $15,528
Non Current Accrued Expenses $7,644,962 $6,581,387 $6,576,359 $8,917,199
Long Term Capital Lease Obligation $18,707,057 $20,540,067 $28,542,462 $29,569,657
Current Deferred Revenue $14,152,111 $6,824,950 $8,785,436 $14,906,906
Current Capital Lease Obligation $6,199,996 $6,720,988 $6,875,378 $5,311,367
Line Of Credit $45,839,010 $78,967,621 $46,112,150 $22,995,221
Current Accrued Expenses $68,205,433 $80,984,598 $57,236,652 $11,092,707
Investments And Advances $62,406,939 $69,825,343 $58,371,063 $64,754,138
Goodwill $84,621,042 $84,621,042 $85,095,894 $85,095,894
Net PPE $587,396,759 $593,276,145 $552,198,968 $511,008,070
Accumulated Depreciation $-73,715,111 $-59,457,559 $-58,273,608 $-47,967,047
Gross PPE $661,111,870 $652,733,704 $610,472,576 $558,975,117
Leases $11,519,202 $11,487,998 $12,091,805 $11,095,960
Construction In Progress $372,941,063 $367,078,092 $365,413,964 $316,606,202
Other Properties $147,235,460 $147,587,422 $104,241,424 $106,413,086
Machinery Furniture Equipment $7,672,468 $8,555,182 $9,274,781 $9,132,517
Buildings And Improvements $121,743,677 $118,025,011 $119,450,603 $115,727,352
Properties $0 $0 $0 $0
Inventories Adjustments Allowances $-79,857 $-87,399 $-85,033 $-89,765
Finished Goods $1,083,687 $405,200 $596,856 $1,463,451
Raw Materials $5,793,614 $4,627,556 $5,454,814 $11,171,972
Other Short Term Investments $148 $19,908,163 $0 -
Available For Sale Securities - - $2,798,539 $7,408,349
Fetched: 2026-06-14
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-43,353,096 $-119,575,712 $-58,618,471 $-88,951,649
Operating Activities
Operating Cash Flow $-29,846,347 $-58,820,331 $-40,885,372 $-32,045,367
Cash Flow From Continuing Operating Activities $-29,846,347 $-58,820,331 $-40,885,372 $-32,045,367
Operating Gains Losses $-7,160,645 $-7,117,463 $-9,304,505 $6,342,260
Investing Activities
Capital Expenditure $-13,506,750 $-60,755,381 $-17,733,099 $-56,906,281
Investing Cash Flow $7,980,508 $-87,760,303 $-7,051,211 $-17,567,322
Cash Flow From Continuing Investing Activities $7,980,508 $-87,760,303 $-7,051,211 $-17,567,322
Net Other Investing Changes - - - $36,324,363
Financing Activities
Financing Cash Flow $29,167,268 $169,478,548 $38,102,509 $56,652,218
Cash Flow From Continuing Financing Activities $29,167,268 $169,478,548 $38,102,509 $56,652,218
Net Other Financing Charges $14,312,121 $25,903,637 $35,229,733 $-12,261,722
Dividends Received Cfi $471,451 $1,478,830 $1,777,850 $754,351
Issuance Of Capital Stock - $75,497,545 $0 $0
Net Common Stock Issuance - $75,497,545 $0 $0
Common Stock Issuance - $75,497,545 $0 $0
Other
Repayment Of Debt $-128,746,827 $-259,024,243 $-66,609,331 $-58,354,795
Issuance Of Debt $143,601,974 $402,599,154 $69,482,107 $127,268,736
Interest Paid Supplemental Data $27,060,526 $27,846,968 $22,531,312 $21,481,047
Income Tax Paid Supplemental Data $16,119 $21,887 $132,799 $445,572
End Cash Position $44,173,847 $35,045,619 $13,371,437 $23,564,127
Beginning Cash Position $35,045,619 $13,371,437 $23,564,127 $23,500,242
Effect Of Exchange Rate Changes $1,826,799 $-1,223,732 $-358,616 $-6,975,643
Changes In Cash $7,301,429 $22,897,914 $-9,834,074 $7,039,528
Net Issuance Payments Of Debt $14,855,147 $143,574,911 $2,872,776 $68,913,940
Net Short Term Debt Issuance $-11,510,476 $43,532,330 $-15,551,824 $2,938,732
Short Term Debt Payments $-64,633,909 $-53,286,548 $-65,491,187 $-29,221,393
Short Term Debt Issuance $53,123,433 $96,818,878 $49,939,363 $32,160,125
Net Long Term Debt Issuance $26,365,624 $100,042,581 $18,424,600 $65,975,209
Long Term Debt Payments $-64,112,917 $-205,737,695 $-1,118,144 $-29,133,403
Long Term Debt Issuance $90,478,541 $305,780,276 $19,542,744 $95,108,611
Net Investment Purchase And Sale $19,908,015 $-14,739,059 $0 $1,767,054
Sale Of Investment $19,908,015 $15,518,846 $0 $1,767,054
Net Business Purchase And Sale $-1,479 $-13,744,693 $8,858,194 $-340,131
Sale Of Business $0 $1,339,377 $8,872,982 $0
Purchase Of Business $-1,479 $-15,084,070 $-14,788 $-340,131
Net Intangibles Purchase And Sale $-4,436 $-1,502,492 $-622,735 $-152,763
Purchase Of Intangibles $-4,436 $-1,502,492 $-622,735 $-152,763
Net PPE Purchase And Sale $-12,393,042 $-59,252,889 $-17,064,520 $-55,920,197
Sale Of PPE $1,109,271 $0 $45,844 $833,321
Purchase Of PPE $-13,502,313 $-59,252,889 $-17,110,363 $-56,753,518
Change In Working Capital $-14,468,729 $-22,083,818 $-8,135,194 $15,532,599
Change In Other Working Capital $5,846,408 $-456,811 $-6,089,676 $8,454,178
Change In Other Current Liabilities $-2,354,002 $-2,858,579 $-2,683,634 $-434,037
Change In Other Current Assets $-141,672 $-67,730 $239,275 $-2,218
Change In Payables And Accrued Expense $-40,719,004 $28,199,077 $10,572,454 $33,580,837
Change In Accrued Expense $-23,513,995 $14,423,329 $8,134,750 $16,639,208
Change In Payable $-17,205,009 $13,775,749 $2,437,704 $16,941,629
Change In Account Payable $-18,084,321 $13,760,813 $2,333,446 $16,820,661
Change In Tax Payable $879,313 $14,936 $104,258 $120,968
Change In Income Tax Payable $879,313 $14,936 $104,258 $120,968
Change In Prepaid Assets $23,850,577 $-49,637,978 $-22,143,711 $-19,247,865
Change In Inventory $-1,859,777 $960,944 $6,579,169 $-6,913,532
Change In Receivables $908,741 $1,777,258 $5,390,928 $95,237
Changes In Account Receivables $908,741 $1,777,258 $5,390,928 $95,237
Other Non Cash Items $24,716,580 $31,909,759 $28,445,599 $50,861,266
Stock Based Compensation $0 $0 $0 $-875,320
Unrealized Gain Loss On Investment Securities $0 $-1,078,067 $0 $0
Provisionand Write Offof Assets $-1,009,745 $18,958,014 $9,569,807 $798,568
Asset Impairment Charge $3,277,088 $0 $0 $0
Deferred Tax $-1,163,544 $-2,314,665 $-1,928,247 $-10,625,101
Deferred Income Tax $-1,163,544 $-2,314,665 $-1,928,247 $-10,625,101
Depreciation Amortization Depletion $22,072,431 $19,336,743 $18,996,168 $19,640,938
Depreciation And Amortization $22,072,431 $19,336,743 $18,996,168 $19,640,938
Amortization Cash Flow $6,765,353 $6,799,958 $6,851,421 $6,524,895
Amortization Of Intangibles $6,765,353 $6,799,958 $6,851,421 $6,524,895
Depreciation $15,307,078 $12,536,785 $12,144,747 $13,116,043
Earnings Losses From Equity Investments $-7,470,755 $-1,859,777 $-8,619,659 $-2,609,692
Gain Loss On Sale Of PPE $310,111 $1,938,747 $-9,169 $444
Gain Loss On Sale Of Business $0 $-7,171,884 $94,349 $9,101,610
Net Income From Continuing Operations $-56,109,783 $-96,430,833 $-78,529,000 $-113,720,579
Purchase Of Investment - $-30,257,905 $0 $0
Gain Loss On Investment Securities - $-24,549 $-770,027 $-150,101
Fetched: 2026-06-14